日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

CD22靶向CAR T细胞疗法治疗CD19靶向CAR T细胞疗法后进展的大B细胞淋巴瘤:一项剂量探索性1期研究

Frank, Matthew J; Baird, John H; Kramer, Anne Marijn; Srinagesh, Hrishikesh K; Patel, Shabnum; Brown, Annie Kathleen; Oak, Jean S; Younes, Sheren F; Natkunam, Yasodha; Hamilton, Mark P; Su, Yi-Jiun; Agarwal, Neha; Chinnasamy, Harshini; Egeler, Emily; Mavroukakis, Sharon; Feldman, Steven A; Sahaf, Bita; Mackall, Crystal L; Muffly, Lori; Miklos, David B

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders

多模态分析揭示了区分EBV阳性和EBV阴性移植后淋巴增殖性疾病的肿瘤和免疫特征。

Jiaying Toh ,Andrea J Reitsma ,Tetsuya Tajima ,Sheren F Younes ,Chimere Ezeiruaku ,Kayla C Jenkins ,Josselyn K Peña ,Shuchun Zhao ,Xi Wang ,Esmond Y Z Lee ,Marla C Glass ,Laurynas Kalesinskas ,Ananthakrishnan Ganesan ,Irene Liang ,Joy A Pai ,James T Harden ,Francesco Vallania ,Edward A Vizcarra ,Govind Bhagat ,Fiona E Craig ,Steven H Swerdlow ,Julie Morscio ,Daan Dierickx ,Thomas Tousseyn ,Ansuman T Satpathy ,Sheri M Krams ,Yasodha Natkunam ,Purvesh Khatri ,Olivia M Martinez

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

大B细胞淋巴瘤中针对CD19的工程化T细胞疗法产生耐药性的决定因素

Brian J Sworder,David M Kurtz,Stefan K Alig,Matthew J Frank,Navika Shukla,Andrea Garofalo,Charles W Macaulay,Mohammad Shahrokh Esfahani,Mari N Olsen,James Hamilton,Hitomi Hosoya,Mark Hamilton,Jay Y Spiegel,John H Baird,Takeshi Sugio,Mia Carleton,Alexander F M Craig,Sheren F Younes,Bita Sahaf,Natasha D Sheybani,Joseph G Schroers-Martin,Chih Long Liu,Jean S Oak,Michael C Jin,Sara Beygi,Andreas Hüttmann,Christine Hanoun,Ulrich Dührsen,Jason R Westin,Michael S Khodadoust,Yasodha Natkunam,Robbie G Majzner,Crystal L Mackall,Maximilian Diehn,David B Miklos,Ash A Alizadeh

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

人类SARS-CoV-2感染和疫苗接种中的免疫印迹、变异株识别广度和生发中心反应

Katharina Röltgen ,Sandra C A Nielsen ,Oscar Silva ,Sheren F Younes ,Maxim Zaslavsky ,Cristina Costales ,Fan Yang ,Oliver F Wirz ,Daniel Solis ,Ramona A Hoh ,Aihui Wang ,Prabhu S Arunachalam ,Deana Colburg ,Shuchun Zhao ,Emily Haraguchi ,Alexandra S Lee ,Mihir M Shah ,Monali Manohar ,Iris Chang ,Fei Gao ,Vamsee Mallajosyula ,Chunfeng Li ,James Liu ,Massa J Shoura ,Sayantani B Sindher ,Ella Parsons ,Naranjargal J Dashdorj ,Naranbaatar D Dashdorj ,Robert Monroe ,Geidy E Serrano ,Thomas G Beach ,R Sharon Chinthrajah ,Gregory W Charville ,James L Wilbur ,Jacob N Wohlstadter ,Mark M Davis ,Bali Pulendran ,Megan L Troxell ,George B Sigal ,Yasodha Natkunam ,Benjamin A Pinsky ,Kari C Nadeau ,Scott D Boyd

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma

CD22靶向CAR T细胞疗法可使CD19靶向CAR难治性大B细胞淋巴瘤患者达到完全缓解

Baird, John H; Frank, Matthew J; Craig, Juliana; Patel, Shabnum; Spiegel, Jay Y; Sahaf, Bita; Oak, Jean S; Younes, Sheren F; Ozawa, Michael G; Yang, Eric; Natkunam, Yasodha; Tamaresis, John; Ehlinger, Zachary; Reynolds, Warren D; Arai, Sally; Johnston, Laura; Lowsky, Robert; Meyer, Everett; Negrin, Robert S; Rezvani, Andrew R; Shiraz, Parveen; Sidana, Surbhi; Weng, Wen-Kai; Davis, Kara L; Ramakrishna, Sneha; Schultz, Liora; Mullins, Chelsea; Jacob, Allison; Kirsch, Ilan; Feldman, Steven A; Mackall, Crystal L; Miklos, David B; Muffly, Lori

Pomegranate Peel Extract Is a Potential Alternative Therapeutic for Giardiasis

石榴皮提取物是治疗贾第虫病的潜在替代疗法

El-Kady, Asmaa M; Abdel-Rahman, Iman A M; Fouad, Samer S; Allemailem, Khaled S; Istivan, Taghrid; Ahmed, Sheren F M; Hasan, Al Shaimaa; Osman, Heba A; Elshabrawy, Hatem A

Assessment of the Effect of Metabolic Syndrome on the Autophagy Marker LC3 in Psoriasis Vulgaris Patients: A Cross-Sectional Study

代谢综合征对寻常型银屑病患者自噬标志物LC3影响的评估:一项横断面研究

Nada, Essam A; Muhammad, Eman M S; Ahmed, Sheren F M; Tamam, Asmaa M S; Abdelhamed, Amr

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma

LMO2 和 BCL6 与原发性中枢神经系统淋巴瘤患者的生存率提高相关

Lossos, Chen; Bayraktar, Soley; Weinzierl, Elizabeth; Younes, Sheren F; Hosein, Peter J; Tibshirani, Robert J; Sutton Posthumus, Jocelyn; DeAngelis, Lisa M; Raizer, Jeffrey; Schiff, David; Abrey, Lauren; Natkunam, Yasodha; Lossos, Izidore S

Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components

滤泡性淋巴瘤的免疫结构模式:HGAL 和 LMO2 在检测滤泡间成分和弥漫成分中的有效性

Younes, Sheren F; Beck, Andrew H; Lossos, Izidore S; Levy, Ronald; Warnke, Roger A; Natkunam, Yasodha